Evidence map›Paper›PMID 37998763›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Spread of

Gabriela Chichón, María López, María de Toro, Lidia Ruiz-Roldán, Beatriz Rojo-Bezares, Yolanda Sáenz

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Genomic Insights into Carbapenem-ResistantJournal of clinical medicine · 2026
    Article
  2. Within-host adaptation mutations associated with persistent colonization ofFrontiers in cellular and infection microbiology · 2026
    Article
  3. Adaptive evolution ofMicrobial genomics · 2026
    Article
  4. Article
  5. JAC-antimicrobial resistance · 2025
    Article
  6. Article
  7. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025
    Review
  8. High-riskHeliyon · 2025
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gabriela ChichónÁrea de Microbiología Molecular, Centro de Investigación Biomédica de La Rioja (CIBIR), C/Piqueras 98, 26006 Logroño, Spain.ORCID 0000-0002-8763-9389
María LópezÁrea de Microbiología Molecular, Centro de Investigación Biomédica de La Rioja (CIBIR), C/Piqueras 98, 26006 Logroño, Spain.ORCID 0000-0002-3834-4891
María de ToroPlataforma de Genómica y Bioinformática, Centro de Investigación Biomédica de La Rioja (CIBIR), C/Piqueras 98, 26006 Logroño, Spain.ORCID 0000-0003-3329-0203
Lidia Ruiz-RoldánJoint Research Unit "Infection and Public Health" FISABIO-University of Valencia, Institute for Integrative Systems Biology I2SysBio (CSIC-UV), Av. de Catalunya 21, 46020 Valencia, Spain.ORCID 0000-0001-8090-4330
Beatriz Rojo-BezaresÁrea de Microbiología Molecular, Centro de Investigación Biomédica de La Rioja (CIBIR), C/Piqueras 98, 26006 Logroño, Spain.ORCID 0000-0003-2742-0980
Yolanda SáenzÁrea de Microbiología Molecular, Centro de Investigación Biomédica de La Rioja (CIBIR), C/Piqueras 98, 26006 Logroño, Spain.ORCID 0000-0002-2457-4258

Funding

Gobierno de La Rioja Gabriela Chichón predoctoral fellowshipInstituto de Salud Carlos III FIS project number PI20/00356
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biofilmcystic fibrosislasRmotilitypigmentresistomeST274virulencewhole genome sequencing

Identifiers

PMID37998763
PMCPMC10668709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.